Science Explorer Back to mapMap
Discussion
Researcher · Prisma Health · United States

Julie Martin

Julie Martin publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer Genomics and Diagnostics, Galectins and Cancer Biology and RNA modifications and cancer.

ORCID 0000-0003-1829-4994 OpenAlex
World rank
#214,467
of 7,710,434 ranked researchers
Rank in United States
#79,444
of 1,627,098
Works
101
Citations
30k
Citations per work
294.5
h-index
37
i10-index 43Top 8.9% in Molecular Biology
Julie Martin

What does Julie Martin research?

Julie Martin's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (23%), Immunology and Microbiology (8%).

Life Sciences: 43 works · 42.4% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 34.6% of their workMolecular Biology: 24 works · 24.2% of their workCancer Research: 11 works · 10.4% of their workImmunology and Microbiology: 8 works · 7.8% of their workImmunology: 8 works · 7.8% of their workEverything else: 35 works · 34.6% of their workHealth Sciences: 23 works · 23.0% of their workMedicine: 23 works · 23.0% of their workOncology: 13 works · 13.0% of their workPulmonary and Respiratory Medicine: 7 works · 6.7% of their workPathology and Forensic Medicine: 3 works · 3.3% of their workTHEIR WORKJulie Martin101works
Life Sciences42%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3534.6%
    2. Immunology and Microbiology87.8%
  2. Everything else3534.6%
    1. Medicine2323.0%
  1. 1Molecular Biology24% of their works
  2. 2Oncology13% of their works
  3. 3Cancer Research10% of their works
  4. 4Immunology8% of their works
  5. 5Pulmonary and Respiratory Medicine7% of their works
  6. 6Pathology and Forensic Medicine3% of their works

Research topics

Which keywords describe Julie Martin's research?

The keywords of their largest research topics: Targeted Therapy, Angiogenesis, Cancer, Cancer Genomics, Mutational Signatures, Galectins, Immune Regulation and Cancer Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy302 topics
  2. Angiogenesis222 topics
  3. Cancer222 topics
  4. Cancer Genomics221 topic
  5. Mutational Signatures221 topic
  6. Galectins151 topic
  7. Immune Regulation151 topic
  8. Cancer Therapy132 topics
  9. Tumor Microenvironment122 topics
  10. ALK Inhibitors81 topic
  11. EGFR Mutations81 topic
  12. RNA methylation81 topic
  13. m6A-seq81 topic
  14. Fibroblast Activation Protein71 topic
  15. Glycans71 topic
  16. Glycosylation71 topic
  17. Immunosuppression71 topic
  18. Cell Cycle61 topic
  19. p5361 topic
  20. Pancreatic Cancer51 topic
  21. Surgical Complications51 topic

Where does Julie Martin work?

Julie Martin's main affiliation in the publication record is Prisma Health, United States.

How many publications and citations does Julie Martin have?

OpenAlex counts 101 works and 29,746 citations for Julie Martin, an h-index of 37, ranking #214,467 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Julie Martin

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Julie Martin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.